Novo Nordisk Inc. v. Aurobindo Pharma Ltd.
Novo Nordisk Inc. v. Aurobindo Pharma Ltd.
Opinion
Case: 12-1388 Document: 28 Page: 1 Filed: 09/26/2012
NOTE: This order is nonprecedential.
Wntteb ~tate~ QCourt of §ppeaI~ for tbe jfeberaI QCircuit
NOVO NORDISK INC. AND NOVO NORDISK A1S, Plaintiffs-Appellants, v. AUROBINDO PHARMA LTD. AND AUROBINDO PHARMA USA, INC., Defendants-Appellees.
2012-1388
Appeal from the United States District Court for the District of New Jersey in case no. 12-CV-1026, Judge Freda L. Wolfson.
ON MOTION
ORDER The parties jointly move to stay proceedings in this appeal pending the final disposition of Novo Nordisk AIS v. Caraco Pharmaceutical Laboratories, Ltd., No. 2011- 1223. Upon consideration thereof, Case: 12-1388 Document: 28 Page: 2 Filed: 09/26/2012
NOVO NORDISK INC. V. AUROBINDO PHARMA LTD. 2
IT Is ORDERED THAT: (1) The motion to stay proceedings in 2012-1388 is granted. The parties are directed to inform this court within 10 days of the final disposition of 2011-1223 how they believe this appeal should proceed. (2) A copy of this order shall be transmitted to the merits panel assigned to Novo Nordisk AIS v. Caraco Pharmaceutical Laboratories, Ltd., No. 2011-1223.
FOR THE COURT
SEP 262012 /s/ Jan Horbaly Date Jan Horbaly Clerk
FILED cc: Mark Andrew Perry, Esq. u.s.THE FEDERAL CIRCUITFOR COURT OF APPEALS Edward John Pardon, Esq. SEP 26 ZOlZ s26 JAN HORBALY Cl£RK
Reference
- Status
- Unpublished